Target- |
MechanismImmunomodulators |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
|
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
MechanismABCG2 inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Kenjockety Biotechnology LLC
0 Patents (Medical) associated with Kenjockety Biotechnology LLC
100 Deals associated with Kenjockety Biotechnology LLC
100 Translational Medicine associated with Kenjockety Biotechnology LLC